Video

Digital Economy: The digitisation of healthcare w/ Jackie Hunter

What unique challenges surround the application of digital technologies in healthcare and how do we overcome them?

In this latest Digital Economy podcast from The Economist, Intelligence Unit host Pete Swabey discusses these challenges with Prof. Jackie Hunter, CE Clinical and Strategic Partnerships at BenevolentAI, Professor Ann Blandford, deputy director for digital health at the UCL Institute of Healthcare Engineering and Elizabeth Sukkar, Managing Editor and Global Editorial lead for healthcare at The EIU.

There are arguably few applications of digital technology more worthwhile than human health, however integrating technologies into healthcare systems is uniquely complex. This podcast provides an introduction to some of the challenges that healthcare providers face in their pursuit of digital innovation, and explores some of the paths forward. This episode touches upon issues ranging from health literacy, to the sensitivity of health data and the need for trust and transparency.

More Posts

You Might Also Like

Blog
Tech Nation Visa: the gateway to world-leading UK tech jobs
Drawing attention to the Tech Nation Visa, a great initiative that enables the brightest international talent to live and work in the UK.
Feb 19, 2021
News
BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial
A molecule designed and developed by BenevolentAI to treat mild to moderate Atopic Dermatitis has entered clinical trials.
Feb 11, 2021
News
BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target
BenevolentAI and AstraZeneca hit collaboration milestone with an AI-generated CKD target from the partnership entering AstraZeneca’s portfolio.
Jan 27, 2021
News
ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients
Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.
Jan 15, 2021
Blog
Joanna Shields speaks at the Global Partnership on Artificial Intelligence
BenevolentAI CEO Joanna Shields opened the final plenary of the Global Partnership on Artificial Intelligence (GPAI) summit with a powerful message on the future of AI.
Dec 11, 2020
Blog
BenevolentAI wins Innovation Award at 2020 Scrip Awards
BenevolentAI wins the Innovation Award at the prestigious 2020 Scrip Awards for our work in artificial intelligence applied drug discovery.
Dec 11, 2020